ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1756 • 2012 ACR/ARHP Annual Meeting

    Peripheral Blood B Cell Subsets and BAFF/APRIL Receptor Expression, Together with Circulating BAFF and APRIL Levels, Are Disturbed in Rheumatoid Arthritis but Not in Ankylosing Spondylitis

    Béatrice Gaugler1, Caroline Laheurte2, Ewa Bertolini3, Daniel Wendling4, Philippe Saas5, Eric Toussirot6 and CIC BT5067, 1EFS Bourgogne Franche Comté, INSERM UMR1098 / Etablissement Français du Sang / Université de Franche Comté, Besançon, France, 2Etablissement Français du Sang/ Université de Franche Comté / CBT506 / CHRU, INSERM UMR1098 / Plateforme Biomonitoring, Besançon, France, 3University Hospital, Rheumatology, Besançon, France, 4Service de Rhumatologie, Minjoz University Hospital, Besancon, France, 5Etablisement Français du Sang ; Université de Franche Comté, INSERM UMR1098, Besançon, France, 6Université de Franche Comté , CHRU, CIC Biotherapy 506 and Rheumatology and EA 4266 Pathogens and Inflammation, Besançon, France, 7Chru, Clinical Investigation Center Biotherapy, Besançon, France

    Background/Purpose: B cells play a critical role in systemic autoimmune disease and especially rheumatoid arthritis (RA). BAFF and APRIL are involved in B cell activation…
  • Abstract Number: 1757 • 2012 ACR/ARHP Annual Meeting

    B Cell Activating Factor Receptor Expression After Rituximab: Comparison of Patients with Rheumatoid Arthritis and Thrombotic Thrombocytopenic Purpura

    Elena Becerra1, Maria J. Leandro1, Edward O. Heelas2, John P. Westwood2, Inmaculada de la Torre3, Marie A. Scully2 and Geraldine Cambridge1, 1Rheumatology, Rheumatology, University College London, London, United Kingdom, 2Hematology, Hematology, University College London, London, United Kingdom, 3Rheumatology, Rheumatology, Gregorio Marañón Hospital, Madrid, Spain

    Background/Purpose: B cell depletion therapy based on rituximab (RTX) is an effective therapy for Rheumatoid Arthritis (RA) and for Thrombotic Thrombocytopenic Purpura (TTP). Serum B…
  • Abstract Number: 1717 • 2012 ACR/ARHP Annual Meeting

    Autologous Lipostructure in the Treatment of Fibrotic Perioral Changes in Systemic Sclerosis: A Pilot Study

    Nicoletta Del Papa1, Fabio Caviggioli2, Domenico Sambataro3, Eleonora Zaccara1, Gabriele Di Luca4, Valeriano Vinci2 and Marco Klinger5, 1UOC Day Hospital Reumatologia, G. Pini Hospital, Milano, Italy, 2UOC Chirurgia Plastica,, UOC Chirurgia Plastica, Multimedica Holding SpA, Università degli Studi di Milano, Milano, Italy, 3UOC Day Hospital Reumatologia,, G. Pini Hospital, Milano, Italy, 4UOS Chirurgia Vascolare,, Osp. G. Pini, Milano, Italy, 5UOC Chirurgia Plastica 2, Istituto Clinico Humanitas, Università degli Studi di Milano;, Milano, Italy

    Background/Purpose: Systemic Sclerosis (SSc) is an autoimmune disease characterized by varying degree of fibrosis in skin and other tissues. Therapeutic options for fibrotic changes are very…
  • Abstract Number: 1718 • 2012 ACR/ARHP Annual Meeting

    Cost Effectiveness of Nurse-Led Care for People with Rheumatoid Arthritis: A Multicentre RCT

    Mwidimi Ndosi1, Martyn Lewis2, Claire Hale3, Howard Bird4, Sarah Ryan2, Helen Quinn4, Elizabeth McIvor5, Julia Taylor6, Gail Burbage7, Deborah Bond8, Jo White9, Debbie Chagadama10, Sandra Green11, Lesley Kay12, Adrian V. Pace13, Victoria Bejarano14, Paul Emery15 and Jackie Hill16, 1Division of Rheumatic and Musculoskeletal Disease, University of Leeds, Leeds, United Kingdom, 2Keele University, Staffordshire, United Kingdom, 3School of Healthcare, University of Leeds, Leeds, United Kingdom, 4University of Leeds, Leeds, United Kingdom, 5Stobhill Hospital, Glasgow, UK, Glasgow, United Kingdom, 6Rheumatology Centre, Poole Hospital NHS Trust, Poole, United Kingdom, 7King's Mill Hospital, Mansfield, United Kingdom, 8Queen Elizabeth Hospital King's Lynn, King's Lynn, United Kingdom, 9Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, 10Rheumatology, Royal London Hospital, London, United Kingdom, 11Rheumatology, Weston General Hospital, Weston-Super-Mare, United Kingdom, 12Department of Rheumatology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom, 13Rheumatology, Russells Hall Hospital, Dudley, United Kingdom, 14Rheumatology, Barnsley Hospital, Barnsley, United Kingdom, 15Medicine, Leeds Musculoskeletal Biomedical Research Unit, Leeds, United Kingdom, 16Acumen, University of Leeds, Leeds, United Kingdom

    Background/Purpose: Despite the establishment of the innovative rheumatology nurse-led clinics (NLC) in the UK, the evidence of their cost-effectiveness is unknown. This study aimed at…
  • Abstract Number: 1719 • 2012 ACR/ARHP Annual Meeting

    What Do Patients Put up with for the Benefit They Get From Methotrexate?

    Sandra M. Robinson1, Peta S. Heslop1 and David Walker2, 1R&D, North Tyneside General Hospital, North Shields, United Kingdom, 2Dept of Rheumatology, Freeman Hospital, Newcastle Upon Tyne, United Kingdom

    Background/Purpose: As with all effective drugs, Methotrexate (MTX) comes with a range of side effects. Some such as pneumonitis are severe enough to require the…
  • Abstract Number: 1720 • 2012 ACR/ARHP Annual Meeting

    Cardiovascular Risk Management in Rheumatoid Arthritis Is Nurse Led Intervention Effective?

    Fiona Niddrie1 and Gabor AC Major2, 1Rheumatology, Bone and Joint Institute; Royal Newcastle Centre, Newcastle, Australia, 2Rheumatology, Bone&Joint Institute; Royal Newcastle Centre, Newcastle, Australia

    Background/Purpose: There is a recognised increase in the incidence of heart disease in patients with rheumatoid arthritis (RA) Surveys of usual practice however frequently show…
  • Abstract Number: 1721 • 2012 ACR/ARHP Annual Meeting

    Development of User-Focused Standards of Care for Rheumatoid Arthritis the Www.Eumusc.Net Project – Work Package 5

    Michaela Stoffer1, Josef S. Smolen2, Anthony D. Woolf3, Tanja A. Stamm4 and EUMUSC.net working group WP 55, 1Internal Medicine III, division of rheumatology, Medical University of Vienna, Vienna, Austria, 2Division of Rheumatology, Department of Internal Medicine III,, Medical University of Vienna and Hietzing Hospital, Vienna, Austria, 3Rheumatology Dept, Royal Cornwall Hospital, Truro Cornwall, United Kingdom, 4Rheumatology, Medical University of Vienna, Vienna, Austria, 5Royal Cornwall Hospital Treliske, Truro Cornwall, United Kingdom

    Background/Purpose: The EUMUSC.net project facilitates cooperation between EU Member States and promotes a comprehensive European strategy to optimise musculoskeletal health.The purpose of Work package 5,…
  • Abstract Number: 1722 • 2012 ACR/ARHP Annual Meeting

    Exploring How Patients with Rheumatoid Arthritis Use a Methotrexate Decision Aid for Making Treatment Choices

    Linda C. Li1, Anne F. Townsend2, Paul M. Adam3, Catherine L. Backman4, Sydney Brooks5, Gwen A. Ellert6, Allyson Jones7, Otto Kamensek8, Cheryl Koehn9, Diane Lacaille8, Jenny Leese2, Colleen Maloney8, Elaine Yacyshyn10, Charlene Yousefi8 and Dawn Stacey11, 1Department of Physical Therapy, University of British Columbia, Vancouver, BC, Canada, 2Rheumatology, Arthritis Research Centre of Canada, Richmond, BC, Canada, 3Rheumatology Liaison, Mary Pack Arthritis Centre, Vancouver, BC, Canada, 4Occupational Science & Occupational Therapy, The University of British Columbia, Vancouver, BC, Canada, 5The Arthritis Society, Ontario Division, Toronto, ON, Canada, 6Health Education, Trelle Enterprises Inc, Vancouver, BC, Canada, 7Department of Physical Therapy, University of Alberta, Edmonton, AB, Canada, 8Arthritis Research Centre of Canada, Vancouver, BC, Canada, 9Arthritis Consumer Experts, Vancouver, BC, Canada, 10562 Heritage Med Rsch Ctr, University of Alberta, Edmonton, AB, Canada, 11School of Nursing, University of Ottawa, Ottawa, ON, Canada

    Background/Purpose: For patients with rheumatoid arthritis (RA), making treatment decisions can be overwhelming. The literature describes a sense of ambivalence among patients with chronic diseases…
  • Abstract Number: 1723 • 2012 ACR/ARHP Annual Meeting

    The Development of the Rheumatoid Arthritis Patient Priorities in Pharmacological Intervention Outcome Measures

    Tessa Sanderson1, John R. Kirwan2, Marianne Morris1, Jon Pollock3, Robert Noddings2, Anne Watts2 and Sarah Hewlett4, 1University of the West of England, Bristol, United Kingdom, 2Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, United Kingdom, 3Faculty of Health and Life Sciences, University of the West of England, Bristol, United Kingdom, 4Academic Rheumatology, University of the West of England, Bristol, United Kingdom

    Background/Purpose: Previous research developed a set of 8 priority treatment outcomes generated by patients to complement the professionally developed ACR core set for RA. These…
  • Abstract Number: 1724 • 2012 ACR/ARHP Annual Meeting

    Pandemic Influenza Immunization in Primary Antiphospholipid Syndrome (PAPS): A Trigger to Autoantibody Production?

    Danielle M. Medeiros1, Cleonice Bueno2, Ana Cristina M. Ribeiro1, Ana L. G. Calich1, Karina Rossi Bonfiglioli3, Vilma S. Viana1, Jozelio F. Carvalho4, Clovis Artur Silva5 and Eloisa Bonfá6, 1Division of Rheumatology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 2Division of Rheumatology, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil, 3Divison of Rheumatology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 4Rheumatology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 5Paediatric Rheumatology International Trials Organization (PRINTO), Istituto Giannina Gaslini, Genova, Italy, 6Rheumatology Division, University of Sao Paulo, Sao Paulo, Brazil

    Background/Purpose: There are scarce data suggesting that pandemic influenza vaccination may induce antiphospholipid (APL) autoantibodies in inflammatory rheumatic diseases, particularly in systemic lupus erythematosus patients.…
  • Abstract Number: 1725 • 2012 ACR/ARHP Annual Meeting

    ANTI-Factor Xa Antibodies ARE Significantly Increased in Patients with Systemic LUPUS Erythematosus and Antiphospholipid Syndrome

    Bahar Artim-Esen1, Charis Pericleous2, Ian Mackie3, Yiannis Ioannou4, Anisur Rahman5, David A. Isenberg6 and Ian Giles5, 1Division of Medicine, Centre for Rheumatology, University College London, London, United Kingdom, 2Centre for Rheumatology, Division of Medicine, Centre for Rheumatology, University College London, London, United Kingdom, 3Haemostasis Research Unit, 1st Floor, 51 Chenies Mews, Haemostasis Research Unit, University College London, London, United Kingdom, 4Arthritis Research UK Centre for Adolescent Rheumatology at University College London, Great Ormond Street Hospital and UCLH, University College London, London, United Kingdom, 5Centre for Rheumatology Research,Rayne Institute, 4th Floor, University College London, London, United Kingdom, 6Centre for Rheumatology Research, Rayne Building, 4th Floor, Centre for Rheumatology, Department of Medicine, University College London, London, United Kingdom

    Background/Purpose: Increased levels of antibodies against different serine proteases (SP) have been identified in patients with the Antiphospholipid Syndrome (APS) compared with healthy controls. These…
  • Abstract Number: 1726 • 2012 ACR/ARHP Annual Meeting

    Lack of Correlation Between Mannose-Binding Lectin Gene Polymorphisms and the Thickness of the Carotid Artery Intima-Media (IMT) in Primary Antiphspholipid Syndrome

    Antonio Barrera-Cruz1, Luis J. Jara-Quezada2, Gabriela Medina3 and Miguel A. Saavedra Salinas4, 1División de Excelencia Clínica, Instituto Mexicano del Seguro Social, México, Mexico, 2Direction of Education and Research, Hospital de Especialidades Centro Médico La Raza, IMSS, Mexico City, Mexico, 3Clinical Reseach Unit, Hospital de Especialidades Centro Médico La Raza, IMSS, Mexico City, Mexico, 4Rheumatology, Hospital de Especialidades, Mexico City, Mexico

    Background/Purpose: Serum mannose-binding lectin (MBL) is a recognition molecule of the lectin pathway of complement with antimicrobial and anti-inflammatory actions. Several polymorphisms have been reported…
  • Abstract Number: 1727 • 2012 ACR/ARHP Annual Meeting

    Affinity Purified Antibodies Directed to Domain I of β2GPI Are Pathogenic in a Mouse Model of Thrombosis

    Charis Pericleous1, Patricia Ruiz-Limon2, Zurina Romay-Penabad2, Ana Laura Carrera Marin2, Acely Garza-Garcia3, Lucy Murfitt3, Paul C. Driscoll4, Ian Giles5, Yiannis Ioannou6, Anisur Rahman5 and Silvia S. Pierangeli2, 1Centre for Rheumatology, Division of Medicine, Centre for Rheumatology, University College London, London, United Kingdom, 2Rheumatology/Dept Int Med, University of Texas Medical Branch, Galveston, TX, 3Molecular Structure, MRC National Institute of Medical Research, London, London, United Kingdom, 4Molecular Structure, MRC National Institute of Medical Research, London, United Kingdom, 5Centre for Rheumatology Research,Rayne Institute, 4th Floor, University College London, London, United Kingdom, 6Arthritis Research UK Centre for Adolescent Rheumatology at University College London, Great Ormond Street Hospital and UCLH, University College London, London, United Kingdom

    Background/Purpose: Circulating IgG antiphospholipid antibodies (aPL) against β2-glycoprotein I (aβ2GPI) are a serological hallmark for diagnosis of the antiphospholipid syndrome (APS). We and other groups…
  • Abstract Number: 1728 • 2012 ACR/ARHP Annual Meeting

    Purified IgG From Antiphospholipid Syndrome Patients with Pregnancy Morbidity Alone Inhibit Trophoblast Migration and Activate a TLR4 MyD88 Independent Pathway

    Katie Poulton1, Vera Ripoll1, Charis Pericleous2, Yiannis Ioannou3, Anisur Rahman4 and Ian Giles4, 1Centre for Rheumatology Research, Division of Medicine, University College London, London, United Kingdom, 2Centre for Rheumatology, Division of Medicine, Centre for Rheumatology, University College London, London, United Kingdom, 3Arthritis Research UK Centre for Adolescent Rheumatology at University College London, Great Ormond Street Hospital and UCLH, University College London, London, United Kingdom, 4Centre for Rheumatology Research,Rayne Institute, 4th Floor, University College London, London, United Kingdom

    Background/Purpose: Patients with the Antiphospholipid Syndrome (APS) have circulating antiphospholipid antibodies which cause vascular thrombosis (VT) and/or pregnancy morbidity (PM). Previously we have shown that…
  • Abstract Number: 1729 • 2012 ACR/ARHP Annual Meeting

    Ribophorin II Is Involved in the Tissue Factor Expression Mediated by Phosphatidylserine-Dependent Antiprothrombin Antibody On Monocytes

    Yuichiro Fujieda1, Olga Amengual1, Yusaku Kanetsuka1, Toshio Odani1, Kotaro Otomo1, Kenji Oku2, Toshiyuki Bohgaki1, Tetsuya Horita1, Shinsuke Yasuda1, Kimiko Kuroki3, Katsumi Maenaka3, Masaki Matsumoto4, Shigetsugu Hatakeyama5 and Tatsuya Atsumi6, 1Hokkaido University,Medicine II, Sapporo, Japan, 2Division of Rheumatology, Endocrinology and Nephrology, Hokkaido University Graduate School of Medicine, Sapporo, Japan, 3Hokkaido University,Laboratory of Biomolecular Science, Sapporo, Japan, 4Kyusyu University,Divison of proteomics, Multi-scale Reserch Center for Prevention of Medical Science, Fukuoka, Japan, 5Hokkaido University,Biochemistry, Sapporo, Japan, 6Medicine II, Hokkaido University,Medicine II, Sapporo, Japan

    Background/Purpose: Antiphospholipid syndrome (APS) is characterized by thrombosis and the presence of antiphospholipid antibodies (aPL). Tissue factor (TF), the major initiator of the extrinsic coagulation…
  • « Previous Page
  • 1
  • …
  • 2486
  • 2487
  • 2488
  • 2489
  • 2490
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology